Signal transducer and activator of transcription-5 activation and breast cancer prognosis

Journal of Clinical Oncology

Volumn 22, Issue 11, 2004, Pages 2053-2060

  Nevalainen, Marja T ^a   Xie, Jianwu ^a   Torhorst, Joachim ^a   Bubendorf, Lukas ^a   Haas, Philippe ^a   Kononen, Juha ^a   Sauter, Guido ^a   Rui, Hallgeir ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; STAT5 PROTEIN; TUMOR MARKER; DNA BINDING PROTEIN; MILK PROTEIN; STAT5A PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER GRADING; CANCER GROWTH; CANCER SURVIVAL; CELL DIFFERENTIATION; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME; ADULT; AGED; BREAST TUMOR; DISEASE FREE SURVIVAL; EVALUATION; FEMALE; METABOLISM; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTION AND FORECASTING; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MILK PROTEINS; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; STAT5 TRANSCRIPTION FACTOR; SURVIVAL RATE; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL;

EID: 2942672845     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.11.046     Document Type: Article

References (29)

1. Liu X, Robinson GW, Wagner KU, et al: Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev 11: 179-186, 1997
2. Teglund S, McKay C, Schuetz E, et al: Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93:841-850, 1998
3. Xie J, LeBaron MJ, Nevalainen MT, et al: Role of tyrosine kinase Jak2 in prolactin-induced differentiation and growth of mammary epithelial cells. J Biol Chem 277:14020-14030, 2002
4. Nevalainen MT, Xie J, Bubendorf L, et al: Basal activation of transcription factor signal transducer and activator of transcription (stat5) in nonpregnant mouse and human breast epithelium. Mol Endocrinol 16:1108-1124, 2002
5. Gouilleux F, Wakao H, Mundt M, et al: Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription. Embo J 13:4361-4369, 1994
6. Miyoshi K, Shillingford JM, Smith GH, et al: Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium. J Cell Biol 155:531-542, 2001
7. Ren S, Cai HR, Li M, et al: Loss of Stat5a delays mammary cancer progression in a mouse model. Oncogene 21:4335-4339, 2002
8. Humphreys RC, Hennighausen L: Signal transducer and activator of transcription 5a influences mammary epithelial cell survival and tumorigenesis. Cell Growth Differ 10:685-694, 1999
9. Yamashita H, Iwase H: The role of Stat5 in estrogen receptor-positive breast cancer. Breast Cancer 9:312-318, 2002
10. Widschwendter A, Tonko-Geymayer S, Welte T, et al: Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer. Clin Cancer Res 8:3065-3074, 2002
11. Cotarla I, Ren S, Zhang Y, et al: Stat5a is tyrosine phosphorylated and nuclear localized in a high proportion of human breast cancers. Int J Cancer 108:665-671, 2004
12. Monni O, Barlund M, Mousses S, et al: Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer. Proc Natl Acad Sci U S A 98:5711-5716, 2001
13. Simon R, Panussis S, Maurer R, et al: KIT (CD117)-positive breast cancers are infrequent and lack KIT gene mutations. Clin Cancer Res 10:178-183, 2004
14. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology 19:403-410, 1991
15. International Union Against Cancer: TNM Classification of Malignant Tumors. Berlin, Germany, Springer, 1992
16. Kononen J, Bubendorf L, Kallioniemi A, et al: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4:844-847, 1998
17. Allred DC, Harvey JM, Berardo M, et al: Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 11:155-168, 1998
18. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
19. Cox DR, Hinkley DV, Reid N, et al: Statistical theory and modelling, in Honour of Sir David Cox, FRS (ed 1). London, UK, Chapman and Hall, 1991
20. Hayes DF, Isaacs C, Stearns V: Prognostic factors in breast cancer: Current and new predictors of metastasis. J Mammary Gland Biol Neoplasia 6:375-392, 2001
21. Freije JM, MacDonald NJ, Steeg PS: Nm23 and tumour metastasis: Basic and translational advances. Biochem Soc Symp 63:261-271, 1998
22. Hart IR, Easty D: Tumor cell progression and differentiation in metastasis. Semin Cancer Biol 2:87-95, 1991
23. Rivadeneira DE, Simmons RM, Christos PJ, et al: Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: Analysis in more than 900 patients. J Am Coll Surg 191:1-8, 2000
24. Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2:442-454, 2002
25. Look MP, van Putten WL, Duffy MJ, et al: Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients. J Natl Cancer Inst 94:116-128, 2002
26. Keyomarsi K, Tucker SL, Buchholz TA, et al: Cyclin E and survival in patients with breast cancer. N Engl J Med 347:1566-1575, 2002
27. van de Vijver MJ, He YD, van't Veer LJ, et al: A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347: 1999-2009, 2002
28. van't Veer LJ, Dai H, van de Vijver MJ, et al: Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530-536, 2002
29. Thomssen C, Janicke F: Do we need better prognostic factors in node-negative breast cancer? Eur J Cancer 36:293-398, 2000